Hydrafacial Investor Day Presentation Deck
Our three-year plan
Double net sales (vs. 2022)
$600 - 700mm
2025E net sales
20 - 27% 2022E - 2025E CAGR¹
112
Continued penetration across all channels
Nascency across key geographies
Consumables pull-through
Note: Our achievement of the anticipated results is subject to risks and uncertainties, including those disclosed in our filings with the SEC. The plan does not take into account the impact of any unanticipated
developments in the business or changes in the operating environment, nor does it take into account the impact of our acquisitions, dispositions or financings during 2022. Our plan assumes a largely reopened
global market, which would be negatively impacted if closures or other restrictive measures persist or are reimplemented;
1. Assuming midpoint of previously stated 2022 $340-350mm net sales guidance.
BEAUTYHEALTH™View entire presentation